93 related articles for article (PubMed ID: 1365478)
1. Concerns and choices in general practice.
Mulder JD
Eur J Rheumatol Inflamm; 1991; 11(3):3-6. PubMed ID: 1365478
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in NSAID use among older adults with osteoarthritis.
Dominick KL; Ahern FM; Gold CH; Heller DA
Ann Pharmacother; 2003 Nov; 37(11):1566-71. PubMed ID: 14565813
[TBL] [Abstract][Full Text] [Related]
4. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population.
Rahme E; Choquette D; Beaulieu M; Bessette L; Joseph L; Toubouti Y; LeLorier J
Am J Med; 2005 Nov; 118(11):1262-70. PubMed ID: 16271911
[TBL] [Abstract][Full Text] [Related]
5. Treating osteoarthritis in practice--the TOP Study.
Knott L
Curr Med Res Opin; 2000; 16(2):147-52. PubMed ID: 10893659
[TBL] [Abstract][Full Text] [Related]
6. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
7. Prescribing behaviors of family physicians in the treatment of osteoarthritis.
Holt WS; Mazzuca SA
Fam Med; 1992; 24(7):524-7. PubMed ID: 1397826
[TBL] [Abstract][Full Text] [Related]
8. Defining the problem of treating the patient with hypertension and arthritis pain.
White WB
Am J Med; 2009 May; 122(5 Suppl):S3-9. PubMed ID: 19393824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and potential risks in a convenience sample of general practitioners.
Cutts C; LaCaze A
Aust Fam Physician; 2002 Jun; 31(6):590-2. PubMed ID: 12154611
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.
Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C
Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495
[TBL] [Abstract][Full Text] [Related]
12. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
13. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
Dai C; Stafford RS; Alexander GC
Arch Intern Med; 2005 Jan; 165(2):171-7. PubMed ID: 15668363
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs.
Frank O
Med J Aust; 1999 Oct; 171(7):388-9. PubMed ID: 10590733
[No Abstract] [Full Text] [Related]
15. Nonsteroidal anti-inflammatory drug use in the elderly: issues of compliance and safety.
Kirchner JT
J Am Osteopath Assoc; 1994 Apr; 94(4):300-4. PubMed ID: 8026998
[TBL] [Abstract][Full Text] [Related]
16. Turkish patients with osteoarthritis: their awareness of the side effects of NSAIDs.
Yilmaz H; Gürel S; Ozdemir O
Turk J Gastroenterol; 2005 Jun; 16(2):89-92. PubMed ID: 16252199
[TBL] [Abstract][Full Text] [Related]
17. Older adult osteoarthritis pain management: results from the 2008 National Ambulatory Medical Care Survey.
McDonald DD; Walsh S
J Am Acad Nurse Pract; 2012 Feb; 24(2):107-12. PubMed ID: 22324866
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoutilization and costs of osteoarthritis: changes induced by the introduction of a cyclooxygenase-2 inhibitor into clinical practice.
Russo P; Capone A; Attanasio E; Baio G; Di Martino M; Degli Esposti L; Marchetta F; Buda S; Degli Esposti E; Caprino L
Rheumatology (Oxford); 2003 Jul; 42(7):879-87. PubMed ID: 12730549
[TBL] [Abstract][Full Text] [Related]
19. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs.
Patino FG; Allison J; Olivieri J; Mudano A; Juarez L; Person S; Mikuls TR; Moreland L; Kovac SH; Saag KG
Arthritis Rheum; 2003 Jun; 49(3):293-9. PubMed ID: 12794782
[TBL] [Abstract][Full Text] [Related]
20. The use and safety profile of non-steroidal antiinflammatory drugs among Turkish patients with osteoarthritis.
Yilmaz H; Gürel S; Ozdemir O
Turk J Gastroenterol; 2005 Sep; 16(3):138-42. PubMed ID: 16245223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
